NO974534L - Bestemmelse av cPSA - Google Patents

Bestemmelse av cPSA

Info

Publication number
NO974534L
NO974534L NO974534A NO974534A NO974534L NO 974534 L NO974534 L NO 974534L NO 974534 A NO974534 A NO 974534A NO 974534 A NO974534 A NO 974534A NO 974534 L NO974534 L NO 974534L
Authority
NO
Norway
Prior art keywords
fpsa
cpsa
antibody
specific
binding
Prior art date
Application number
NO974534A
Other languages
English (en)
Norwegian (no)
Other versions
NO974534D0 (no
Inventor
William Jeffrey Allard
Kwok K Yeung
Zeqi Zhou
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27419236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO974534(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/903,750 external-priority patent/US5840501A/en
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO974534D0 publication Critical patent/NO974534D0/no
Publication of NO974534L publication Critical patent/NO974534L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Cephalosporin Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO974534A 1996-10-25 1997-10-01 Bestemmelse av cPSA NO974534L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73838396A 1996-10-25 1996-10-25
US83496997A 1997-04-17 1997-04-17
US08/903,750 US5840501A (en) 1996-10-25 1997-07-31 Determination of cPSA

Publications (2)

Publication Number Publication Date
NO974534D0 NO974534D0 (no) 1997-10-01
NO974534L true NO974534L (no) 1998-04-27

Family

ID=27419236

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974534A NO974534L (no) 1996-10-25 1997-10-01 Bestemmelse av cPSA

Country Status (14)

Country Link
US (2) US5928878A (ja)
EP (1) EP0838680B1 (ja)
JP (1) JP4274330B2 (ja)
AT (1) ATE267399T1 (ja)
AU (1) AU746345B2 (ja)
CA (1) CA2214488C (ja)
CZ (1) CZ295854B6 (ja)
DE (1) DE69729156T2 (ja)
DK (1) DK0838680T3 (ja)
ES (1) ES2221006T3 (ja)
HU (1) HU221350B1 (ja)
IL (1) IL121659A (ja)
NO (1) NO974534L (ja)
PT (1) PT838680E (ja)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19641560A1 (de) * 1996-10-09 1998-04-16 Boehringer Mannheim Gmbh Monoklonale Antikörper gegen einen Komplex aus humanem ACT und einer Serinprotease
CA2243033A1 (en) * 1997-07-31 1999-01-31 Bayer Corporation Determination of psa-act
US6562618B1 (en) * 1997-12-25 2003-05-13 Japan Tobacco, Inc. Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
GB9827845D0 (en) * 1998-12-17 1999-02-10 Scolab S A Immunoassay or proteins
CA2311512A1 (en) * 1999-07-24 2001-01-24 Bayer Corporation Reflex method for the detection of prostate cancer
JP3536731B2 (ja) * 1999-07-28 2004-06-14 富士レビオ株式会社 ＨＩＶ−１ｐ２４抗原の免疫測定方法及び試薬
US6569684B2 (en) 2000-01-06 2003-05-27 University Of Central Florida Method of identifying and treating invasive carcinomas
EP1178317B1 (en) 2000-07-24 2004-11-10 Health Research, Inc. Method for detection of prostate specific membrane antigen in serum
US6379550B1 (en) 2000-07-24 2002-04-30 Health Research, Inc. Method for detecting PSA and its molecular forms using thiophilic gel
DE60137512D1 (de) 2000-08-07 2009-03-12 Univ Vanderbilt Zusammensetzungen und verfahren zum nachweis und zur quantifizierung von cox-2-aktivität und 2-arachidonylglycerin-metaboliten
CA2422856C (en) * 2000-09-25 2012-02-07 Abbott Laboratories Methods and kits for decreasing interferences of assay samples containing plasma or serum in specific binding assays by using a large polycation
US6764825B1 (en) * 2000-10-13 2004-07-20 Tang J. Wang Methods and device for detecting prostate specific antigen (PSA)
US7226749B2 (en) * 2000-12-05 2007-06-05 Zahradnik Richard J Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
US6838264B2 (en) * 2000-12-05 2005-01-04 Immutopics, Inc. Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
WO2003076942A2 (fr) * 2002-03-13 2003-09-18 Biomerieux Quantification de cellules tumorales circulantes issues de cancers solides
US20040018580A1 (en) * 2002-05-10 2004-01-29 Chai Karl X. Synthetic substrates for prostasin
US7666981B1 (en) 2002-05-10 2010-02-23 University Of Central Florida Research Foundation, Inc. Inhibitors of prostasin
US7314709B2 (en) * 2002-08-06 2008-01-01 Vanderbilt University Compositions and methods for detecting and quantifying COX-2 activity by lipoamino acid metabolism
EP1507147A1 (en) * 2003-08-12 2005-02-16 Erasmus University Medical Center Rotterdam Method for detecting low levels of a fusion protein
DE602005010548D1 (de) * 2004-01-28 2008-12-04 Turun Yliopisto Verbessertes verfahren zur diagnose des akuten koronarsyndroms
US8012694B2 (en) 2006-09-14 2011-09-06 Immutopics, Inc. Assay for the detection of phosphorylated PTH
EP2107377A1 (en) * 2008-04-04 2009-10-07 BRAHMS Aktiengesellschaft Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events
CN102066943A (zh) * 2008-04-09 2011-05-18 B.R.A.H.M.S有限公司 用于预测受损峰值耗氧量的内皮素1原
US8658166B2 (en) 2011-11-08 2014-02-25 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
US20130116131A1 (en) 2011-11-08 2013-05-09 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
US8658164B2 (en) 2011-11-08 2014-02-25 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
US8632971B2 (en) 2011-11-08 2014-01-21 Caldera Health Limited Methods and materials for determining the efficacy of prostate cancer therapies
JP6604081B2 (ja) * 2014-08-13 2019-11-13 東ソー株式会社 Ｎ型糖鎖が付加している膵臓リボヌクレアーゼ１の測定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0690203B2 (ja) * 1985-08-23 1994-11-14 中外製薬株式会社 前立腺特異抗原とα▲下１▼−アンチトリプシン複合体の定量方法
SE9002480D0 (sv) * 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
DE4322342A1 (de) * 1993-07-05 1995-02-09 Gif Ges Fuer Immunologische Fo Verfahren für die Differentialdiagnostik des Prostata-Karzinoms
EP0635575A1 (en) * 1993-07-22 1995-01-25 Wallac Oy Monoclonal antibodies against epitopes found in free but not in alpha-1-antichmotrypsin complexed prostate specific antigen
US5599677A (en) * 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
US5698402A (en) * 1995-02-23 1997-12-16 Dianon Systems, Inc. Methods for diagnosing benign prostatic hyperplasia
US5710007A (en) * 1995-09-29 1998-01-20 Luderer; Albert A. Methods for diagnosing prostatic adenocarcinoma

Also Published As

Publication number Publication date
HUP9701717A3 (en) 2000-04-28
CZ335797A3 (cs) 1998-05-13
HUP9701717A2 (hu) 1998-05-28
DK0838680T3 (da) 2004-09-27
CA2214488C (en) 2007-06-19
HU9701717D0 (en) 1997-12-29
US6107049A (en) 2000-08-22
NO974534D0 (no) 1997-10-01
EP0838680A1 (en) 1998-04-29
JPH10177027A (ja) 1998-06-30
DE69729156D1 (de) 2004-06-24
CZ295854B6 (cs) 2005-11-16
CA2214488A1 (en) 1998-04-25
JP4274330B2 (ja) 2009-06-03
AU3926797A (en) 1998-04-30
DE69729156T2 (de) 2005-05-25
EP0838680B1 (en) 2004-05-19
HU221350B1 (en) 2002-09-28
ATE267399T1 (de) 2004-06-15
PT838680E (pt) 2004-08-31
AU746345B2 (en) 2002-04-18
IL121659A0 (en) 1998-02-22
ES2221006T3 (es) 2004-12-16
IL121659A (en) 2000-07-16
US5928878A (en) 1999-07-27

Similar Documents

Publication Publication Date Title
NO974534L (no) Bestemmelse av cPSA
CY1115366T1 (el) Δεικτες ογκου
CA2384579A1 (en) Early cancer tumor marker
KR890015714A (ko) 폐암의 조기 검출 방법
IL142971A0 (en) S100 proteins and autoantibodies as serum markers for cancer
JP2013513815A (ja) 前立腺癌診断用キット及び診断方法
DE3780480T2 (de) Test fuer menschlichen brustkrebs.
ATE378601T1 (de) Diagnostischer test für menschlisches matrix gla- protein und seine verwendung als biomarker
DE69811157D1 (de) Immunoassay zur Bestimmung von PSA-ACT
JP5048207B2 (ja) 敗血症状態の発症および存在を決定するための装置及び方法
Christofidis Scientific background of the project
DK1200826T3 (da) Immunoassay og testanordning med integreret reference
AU2001280912A1 (en) Apparatus and method for determining the onset and presence of sepsis conditions
FI104219B1 (fi) Diagnostinen menetelmä ja testaustarvikesarja multippeliskleroosin määrittämiseksi
Christofidis Scientific background of the project [Radioimmunometric assay for Prostate Specific Antigen (PSA) measurement]
ATE208041T1 (de) A-protein als diagnostikum für krebs
Lynch et al. An Enzyme Immunoassay for Carcinoembryonic Antigen Which Employs Simultaneous Incubation of Specimen with Solid Phase and Enzyme-Conjugated Antibodies
EP1072890A2 (en) Method for the detection of prostate cancer
ITMI962054A1 (it) Saggio per la determinazione di anticorpi anti-endomisio
KR20080040306A (ko) 현장검사용 암 진단 시스템

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application